SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001104659-13-074193
Filing Date
2013-10-07
Accepted
2013-10-07 06:03:53
Documents
4
Group Members
AUTUMN ACQUISITION CORPOTSUKA AMERICA, INC.OTSUKA PHARMACEUTICAL CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A a13-20575_12sctota.htm SC TO-T/A 69859
2 EX-99.(A)(5)(A) a13-20575_12ex99da5a.htm EX-99.(A)(5)(A) 13656
3 GRAPHIC g2057512moi001.jpg GRAPHIC 1972
4 GRAPHIC g2057512moi002.gif GRAPHIC 2844
  Complete submission text file 0001104659-13-074193.txt   92234
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Subject) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-48769 | Film No.: 131137837
SIC: 2834 Pharmaceutical Preparations

Mailing Address SHINAGAWA GRAND CENTRAL TOWER 2-16-4 KONAN, MINATO-KU TOKYO M0 108-8242
Business Address SHINAGAWA GRAND CENTRAL TOWER 2-16-4 KONAN, MINATO-KU TOKYO M0 108-8242 011-81-3-6717-1400
Otsuka Holdings Co., Ltd. (Filed by) CIK: 0001586698 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0314
Type: SC TO-T/A